CompletedNot applicableNCT00282516

Asthma In-Home Monitoring (AIM) Trial

OBJECTIVE: Determine whether home asthma telemonitoring using store-and-forward technology improves outcomes when compared to in-person, office-based visits.

Checked against the public recordLast updated Feb 10, 2025 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations1
SponsorTripler Army Medical Center
01
Study overview

What this study is about

Purpose
Other
Study type
Interventional
Phase
Not applicable
Sponsor
Tripler Army Medical Center
Interventions being studied
Procedure: In-home telemonitoring of pediatric patients with persistent asthma
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Diagnosis of persistent asthma as defined using the NHLBI Expert Panel Report -2 guidelines Assignment of severity classification will be made at the beginning of the study based on severity of disease off therapy. * Dependent of active duty or retired US military personnel * 6 to 17 years of age * Not moving from Oahu for 12 months after entry into study * Ability to receive cable modem hook-up in home * Willingness to learn to record and send MDI + spacer technique and peak flow two times week * Willing to attend asthma education follow-up visits either in person or electronically at 2- weeks, 6- weeks, 3-months and 6-month intervals after initiation into the study. * Willing to complete survey at the end of study period. * Willing to sign informed, written consent Exclusion Criteria: * Diagnosis of mild intermittent asthma as defined by Expert Panel Report -2 guidelines. * \<6 and \>17 years of age * Family leaving Oahu within 12 months * Inability to receive cable modem hook-up in home * Unwilling or unable to learn to record and send MDI + spacer technique and peak flow and/or to attend asthma education follow-up visits either in person or electronically at initiation into study and at 2- weeks, 6- weeks, 3-months and 6 month intervals. * Unwilling to complete survey at the end of study period. * Patients or parents who decline to participate. * Patients with other chronic pulmonary disease (cystic fibrosis, bronchopulmonary dysplasia)

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Tripler Army Medical CenterTripler AMC, Hawaii

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 10, 2025. Always confirm current availability with the study team.

View original record ↗